SDGR
Schrödinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$20.09
−2.99%Aug 14, 2026, 23:42 UTC
On August 14, 2026, Schrodinger Inc's stock price fell 4.8% to $17.58.
Source:Aug 14, 2026, 12:30 UTC
Schrödinger, Inc. granted restricted stock units covering 3,315 shares of common stock to two newly hired employees on August 12, 2026, as inducement grants under its 2021 Inducement Equity Incentive Plan.
Source:Aug 5, 2026, 12:30 UTC
Schrödinger announced a strategic collaboration and software agreement with Bristol Myers Squibb to deploy its agentic AI co-scientist Bunsen within BMS's research organization.
Source:Aug 5, 2026, 00:00 UTC
Schrodinger, Inc. reported its Q2 2026 financial results with total revenue of $58.9 million, net income of $6.0 million, and diluted EPS of $0.08.
Source:Jul 27, 2026, 11:30 UTC
Schrödinger, Inc. launched the early access version of Bunsen, an AI co-scientist for molecular discovery.
Jun 23, 2026, 13:00 UTC
NVIDIA announced the BioNeMo Agent Toolkit, a set of tools for agents to accelerate scientific discovery.
Jun 21, 2026, 13:48 UTC
Schrodinger Inc finalized a transition, separation, and release of claims agreement with its former Chief Commercial Officer and Global Head of Software Sales and Marketing, Mannix Aklian.